Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
- Conditions
- B-Cell Lymphomas
- Registration Number
- NCT01478269
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Brief Summary
This study is a retrospective analysis of an homogeneous population of patients with aggressive B-cell lymphoma and treated upfront with R-CHOP or R-CHOP like regimens to reassess the prognostic factors and hopefully to identify more accurate prognostic subgroups with a clinical and therapeutical relevance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1927
- Histologically confirmed newly diagnosed aggressive B-cell lymphoma according to the current World Health Organisation Classification, from 2001 to 2007.
- Any stage of disease.
- Treatment with R-CHOP or R-CHOP like regimens (+/- transplant).
- Age at least 18 years.
- Availability of tissue biopsy at diagnosis for a possible centralized revision.
- Availability of data on clinical involvement, laboratory, treatment and follow up.
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (39)
Hemocentro-Unicamp
🇧🇷Campinas, Brazil
Centro Medico
🇧🇷Santa Isabel, Brazil
Centro Paulista de Oncologia
🇧🇷Sao Paolo, Brazil
Santa Casa Medical School
🇧🇷Sao Paolo, Brazil
A.O.SS. Biagio, Antonio e Cesare Arrigo
🇮🇹Alessandria, Italy
Centro di riferimento Oncologico Oncologia Medica A
🇮🇹Aviano (Pordenone), Italy
USC Ematologia e Trapianto di Midollo Osseo Ospedali Riuniti di Bergamo
🇮🇹Bergamo, Italy
Presidio Ospedaliero A.Perrino - Divisione di Ematologia
🇮🇹Brindisi, Italy
U.O. di Oncologia Ospedale di Circolo di Busto Arsizio
🇮🇹Busto Arsizio, Italy
Ospedale Civile
🇮🇹Camposanpiero (PD), Italy
Scroll for more (29 remaining)Hemocentro-Unicamp🇧🇷Campinas, Brazil